Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pall Corporation, specialized in filtration, separation and purification techniques, has entered into a definitive merger agreement for the acquisition of ForteBio, a provider of advanced analytical systems to advance discovery and development of biotech drugs.
Subscribe to our email newsletter
ForteBio will provide a range of innovative, label-free protein analysis instruments that will extend Pall’s capabilities in the biopharmaceuticals process monitoring market and in the protein research market.
ForteBio’s portfolio of analytical solutions will enable researchers to measure proteins in real time without the aid of fluorescent, radio or calorimetric labels or markers that can contaminate samples.
Through this, characterization of drug candidates becomes easier and faster there by enabling an improvement in the process development and speed time to market.
The deal is expected to close by February 2012 and the financial terms of the deal have not been revealed.